Toda, Japan

Yuichi Koga

This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuichi Koga. Retrieved from https://idiyas.com/inventor/yuichi-koga-x9dcv79w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuichi Koga: Innovator in Pharmaceutical Chemistry

Introduction

Yuichi Koga is a notable inventor based in Toda, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that exhibit therapeutic potential.

Latest Patents

Koga holds a patent for a pyridopyrimidine or naphthyridine derivative. This compound is characterized by a specific formula where R represents an optionally substituted nitrogen-containing heterocyclic group, and other variations of R include hydrogen or lower alkyl groups. The invention focuses on compounds that demonstrate excellent PDE V inhibitory activities, making them useful in the prophylaxis or treatment of penile erectile dysfunction. Koga's innovative work in this area has the potential to impact the pharmaceutical industry significantly.

Career Highlights

Yuichi Koga is associated with Tanabe Seiyaku Company, Limited, where he continues to advance his research and development efforts. His work has led to the creation of valuable pharmaceutical compounds that address critical health issues.

Collaborations

Koga has collaborated with notable colleagues, including Koichiro Yamada and Masataka Hikota. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Yuichi Koga's contributions to pharmaceutical chemistry, particularly through his patented inventions, highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…